HighTower Advisors’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
VPM
VCM
KBG
PMG
HighTower Advisors's OGN Position: Q1 2026 in Review
HighTower Advisors reduced its Organon & Co (OGN) stake by 4% in Q1 2026, selling an estimated $15.4K and leaving 49,019 shares worth $294K. The position accounts for ﹤0.01% of the portfolio, ranked #3198.
HighTower Advisors first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $3.63M in Q3 2021. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.
- HighTower Advisors held 49,019 shares of Organon & Co worth $294K as of Q1 2026.
- HighTower Advisors sold 2,044 Organon & Co shares in Q1 2026, an estimated $15.4K.
- Organon & Co made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #3198 holding.
- HighTower Advisors first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
- HighTower Advisors's Organon & Co position peaked at $3.63M in Q3 2021.
- 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.
Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.